Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors This is a prospective multicenter phase II trial of gemcitabine, cisplatin, and ifosfamide (GIP) in patients with relapsed non-seminomatous germ-cell tumors (NSGCT) and a predicted favorab...

• Pays France
• Organes Aucun
• Spécialités Aucune

Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary This is a randomized phase III trial comparing cisplatin with or without gemcitabine in patients with carcinoma of unknown primary and a predicted favorable prognosis. The purpose of this...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune